Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.
about
An update on the diagnosis and treatment of Parkinson diseaseAmelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's diseaseThe effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experienceMotor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration.Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease.New and emerging medical therapies in Parkinson's disease.Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.Novel Levodopa Formulations for Parkinson's Disease.Intrajejunal levodopa infusion therapy for Parkinson's disease: practical and pragmatic tips for successful maintenance of therapy.Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease.Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion.Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.Pharmacotherapy and generic health-related quality of life in Parkinson's disease.Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients.Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
P2860
Q30243899-5C5949E5-19D8-4F3E-BEA5-9CBF04C4AAC5Q36709824-0AA4CA14-923E-4C16-9179-12F9183B5082Q36724032-D3624009-78B5-4BFC-B304-4F09ABD8478CQ37342303-FAB0D557-A2CA-4C2D-AD0C-CBC84AA6840EQ37698585-6C1A3ED0-AC1F-4324-B056-F6543B7A3FFCQ38194569-F0BF189A-37A9-418C-B645-B439C10F1FE6Q38371848-DA4E04FE-7D2E-4D19-B4FD-5CFE82C8A83AQ38476557-D5239C72-35A8-4C51-9949-3346EDA58C1BQ38718194-83E48FE8-51BB-4603-B4CC-796616697AFAQ38823793-E0CD47EA-8E2E-4CBA-9DB9-1F7FE566BD9AQ38981419-E79048AB-B449-46DB-9158-1E5258E9F523Q39240060-6B70117B-B6D9-46F2-9C35-4A0BE0CF9296Q45246047-CE4F7891-8B48-4F13-B015-4AE57490884FQ46159643-804C6E06-0C20-4DB2-B04A-7C5F4BC7CC19Q46617404-0F0533F2-33C4-4802-864F-982B21A4287DQ47140289-EC64B0CD-A2C9-48EA-B36A-AF70AF693339Q47652358-91D438C7-335E-4FB2-A37C-36579B93814DQ47740158-111A2B17-CFD2-4F2C-8E3E-D227335B505BQ47914989-63DEF528-0DEB-4C97-AE43-E2E0B90E35D3Q50666990-3608562F-F090-486D-9625-ABA3FC2314CBQ53143036-996BCAF8-1C04-4209-BE2E-49EFB99C21DCQ53661046-CC54FBCF-E284-476C-AA52-F38C5AE1C051Q54478924-7B0BED40-12BB-46A2-AAEA-968FA3B15E7E
P2860
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@en
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@nl
type
label
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@en
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@nl
prefLabel
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@en
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@nl
P2093
P2860
P50
P1433
P1476
Long-term duodenal levodopa in ...... and cognitive follow-up study.
@en
P2093
Alice Marchisio
Claudio De Angelis
Dario Reggio
Elisa Montanaro
Laura Rizzi
Mario Rizzone
Valeria Ricchi
P2860
P2888
P304
P356
10.1007/S00415-012-6597-0
P577
2012-07-08T00:00:00Z